Acute myeloid leukemia is a cancer that affects blood and bone marrow cells and can develop rapidly. Understanding its possible signs, diagnostic tests, and treatment approaches can help people learn how this condition is identified and managed. Symptoms may include fatigue, frequent infections, fever, unusual bruising, or bleeding, although these symptoms can have other causes. Diagnosis generally involves blood tests and bone marrow examinations. Treatment may include chemotherapy, targeted therapy, stem cell transplantation, and supportive care depending on individual medical factors, leukemia characteristics, overall health, and response to treatment throughout the care process.
Acute myeloid leukemia, commonly called AML, is a type of cancer that begins in the bone marrow and affects the production and development of blood cells. It occurs when immature myeloid cells grow and multiply abnormally, interfering with the production of healthy blood cells. Because AML can progress relatively quickly, medical evaluation is important when concerning symptoms or abnormal blood test results are identified. The signs, testing process, and treatment approach can vary based on the characteristics of the leukemia and the individual receiving care.
AML may cause symptoms because abnormal cells can reduce the number of healthy red blood cells, white blood cells, and platelets. Some symptoms can also occur with other medical conditions, so they do not always indicate leukemia. A healthcare professional may consider symptoms alongside laboratory findings and other diagnostic information.
Possible signs and symptoms may include:
Diagnostic testing often begins with a complete blood count, which measures different types of blood cells. If results show unusual cell counts or abnormal cells, additional testing may be recommended.
Common diagnostic procedures include:
These tests can help healthcare teams confirm the diagnosis and classify the leukemia based on biological and genetic features.
Treatment for AML depends on several factors, including age, general health, previous medical conditions, and the genetic or molecular characteristics of the leukemia cells. The goal of treatment may include reducing or eliminating leukemia cells and supporting the recovery of healthy blood cell production.
Treatment approaches may include:
Treatment is often divided into phases. An initial phase may focus on reducing the number of leukemia cells, while later treatment may aim to reduce the risk of the disease returning. Regular blood tests, bone marrow assessments, and medical follow-up may be used to monitor treatment response.
The management of acute myeloid leukemia is individualized, and treatment decisions are made by qualified healthcare professionals based on detailed medical information. Understanding possible symptoms, diagnostic methods, and available treatment approaches can provide useful educational information about how AML is identified and managed. Continued medical monitoring may also help healthcare teams assess treatment response and address complications that can occur during care.